Pursuant to ASX Listing Rule 17.1, THC Global Group Limited (THC Global or the Company) requests a trading
halt in the Company’s securities pending an announcement with respect to the grant of a Manufacture Licence by the Office of Drug Control to the Company’s subsidiary, THC Pharma Pty Ltd.
THANK YOU JESUS!!!!!
Add to My Watchlist
What is My Watchlist?